Articles with public access mandates - Elvira D'Andrea, MD, MPH, PhDLearn more
Not available anywhere: 3
Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom
D Abrahami, E D'Andrea, H Yin, SC Kim, JM Paik, D Wexler, L Azoulay, ...
Diabetes, Obesity and Metabolism 25 (10), 2980-2988, 2023
Mandates: Fonds de recherche du Québec - Santé
Challenges and opportunities for biomarker validation
SP Hey, E D'Andrea, EH Jung, F Tessema, J Luo, B Gyawali, ...
The Journal of Law, Medicine & Ethics 47 (3), 357-361, 2019
Mandates: Arnold Ventures LLC
Surrogate endpoints and drug regulation: what is needed to clarify the evidence
SP Hey, WB Feldman, EH Jung, E D'Andrea, AS Kesselheim
The Journal of Law, Medicine & Ethics 47 (3), 381-387, 2019
Mandates: Arnold Ventures LLC
Available somewhere: 31
Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials
SV Wang, S Schneeweiss, JM Franklin, RJ Desai, W Feldman, EM Garry, ...
Jama 329 (16), 1376-1385, 2023
Mandates: US National Institutes of Health
Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations
E D’andrea, C Marzuillo, C De Vito, M Di Marco, E Pitini, MR Vacchio, ...
Genetics in Medicine 18 (12), 1171-1180, 2016
Mandates: European Commission, Government of Italy
Assessment of the role of niacin in managing cardiovascular disease outcomes: a systematic review and meta-analysis
E D’Andrea, SP Hey, CL Ramirez, AS Kesselheim
JAMA network open 2 (4), e192224-e192224, 2019
Mandates: Arnold Ventures LLC
How is genetic testing evaluated? A systematic review of the literature
E Pitini, C De Vito, C Marzuillo, E D’Andrea, A Rosso, A Federici, ...
European Journal of Human Genetics 26 (5), 605-615, 2018
Mandates: European Commission, Government of Italy
Familial hypercholesterolemia: a systematic review of guidelines on genetic testing and patient management
G Migliara, V Baccolini, A Rosso, E D’Andrea, A Massimi, P Villari, ...
Frontiers in Public Health 5, 252, 2017
Mandates: European Commission
Which Lynch syndrome screening programs could be implemented in the “real world”? A systematic review of economic evaluations
M Di Marco, E D’Andrea, N Panic, V Baccolini, G Migliara, C Marzuillo, ...
Genetics in Medicine 20 (10), 1131-1144, 2018
Mandates: European Commission
Comparing effectiveness and safety of SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2 diabetes and varying baseline HbA1c levels
E D’Andrea, DJ Wexler, SC Kim, JM Paik, E Alt, E Patorno
JAMA internal medicine 183 (3), 242-254, 2023
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
The cost-effectiveness of genetic screening for familial hypercholesterolemia: a systematic review
A Rosso, E Pitini, E D’Andrea, A Massimi, C De Vito, C Marzuillo, P Villari
Ann Ig 29 (5), 464-80, 2017
Mandates: European Commission
Current state of genomic policies in healthcare among EU member states: results of a survey of chief medical officers
W Mazzucco, R Pastorino, T Lagerberg, M Colotto, E d’Andrea, C Marotta, ...
The European Journal of Public Health 27 (5), 931-937, 2017
Mandates: European Commission, Government of Italy
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
E D’Andrea, AS Kesselheim, JM Franklin, EH Jung, SP Hey, E Patorno
Cardiovascular Diabetology 19, 1-11, 2020
Mandates: US National Institutes of Health, Arnold Ventures LLC
A proposal of a new evaluation framework towards implementation of genetic tests
E Pitini, E D’Andrea, C De Vito, A Rosso, B Unim, C Marzuillo, A Federici, ...
PloS one 14 (8), e0219755, 2019
Mandates: European Commission, Government of Italy
Response rates and durations of response for biomarker-based cancer drugs in nonrandomized versus randomized trials
B Gyawali, E D’Andrea, JM Franklin, AS Kesselheim
Journal of the National Comprehensive Cancer Network 18 (1), 36-43, 2020
Mandates: Arnold Ventures LLC
A systematic review and meta-analysis of bevacizumab in first-line metastatic breast cancer: lessons for research and regulatory enterprises
SP Hey, B Gyawali, E D’Andrea, M Kanagaraj, JM Franklin, ...
JNCI: Journal of the National Cancer Institute 112 (4), 335-342, 2020
Mandates: Arnold Ventures LLC
Prevalence of avoidable and bias‐inflicting methodological pitfalls in real‐world studies of medication safety and effectiveness
K Bykov, E Patorno, E D’Andrea, M He, H Lee, JS Graff, JM Franklin
Clinical Pharmacology & Therapeutics 111 (1), 209-217, 2022
Mandates: US National Institutes of Health
Characteristics of clinical trials evaluating biosimilars in the treatment of cancer: a systematic review and meta-analysis
D Bloomfield, E D’Andrea, S Nagar, A Kesselheim
JAMA oncology 8 (4), 537-545, 2022
Mandates: Arnold Ventures LLC
Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia
E D’Andrea, T Lagerberg, C De Vito, E Pitini, C Marzuillo, A Massimi, ...
European Journal of Human Genetics 26 (4), 518-526, 2018
Mandates: European Commission, Government of Italy
Association of sodium-glucose cotransporter-2 inhibitors with incident atrial fibrillation in older adults with type 2 diabetes
M Zhuo, E D’Andrea, JM Paik, DJ Wexler, BM Everett, RJ Glynn, SC Kim, ...
JAMA network open 5 (10), e2235995-e2235995, 2022
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Publication and funding information is determined automatically by a computer program